Furthermore, although four signature molecules (OXCT1, ACAT1, GLUT1, and PFKPF3) were identified in this study to stratify the metabolic subgroups in colon cancer, they may not be the optimal set for other types of cancers. Here, OXCT1 is linked to malignant colon neoplasm.